| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Hologic (NASDAQ:HOLX) reported its Q1 earnings results on Thursday, February 1, 2024 at 04:02 PM.
Here's what investors need to know about the announcement.
Hologic beat estimated earnings by 3.16%, reporting an EPS of $0.98 versus an estimate of $0.95.
Revenue was down $61.00 million from the same period last year.
Last quarter the company beat on EPS by $0.05 which was followed by a 7.34% increase in the share price the next day.
Here's a look at Hologic's past performance:
| Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.84 | 0.88 | 0.88 | 0.91 |
| EPS Actual | 0.89 | 0.93 | 1.06 | 1.07 |
| Revenue Estimate | 940.04M | 957.13M | 958.79M | 1.00B |
| Revenue Actual | 945.30M | 984.40M | 1.03B | 1.07B |
To track all earnings releases for Hologic visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HOLX
